Recombinant human TRAIL (Beijing Sunbio)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human TRAIL (Beijing Sunbio)
Drug Alias NameHuman recombinant Apo2L/TRAILCPT - Beijing Sunbio BiotechRecombinant Apo2L - Beijing Sunbio BiotechRecombinant TRAILHuman recombinant circularly permuted TRAIL - Beijing Sunbio Biotech
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionTumor necrosis factor receptor superfamily member 10B agonistsTumor necrosis factor receptor superfamily member 10A agonists
TargetsTumor necrosis factor receptor superfamily member 10BTumor necrosis factor receptor superfamily member 10A
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesBeijing Sunbio Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Sunbio Biotech
Active IndicationsN/A
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A